Supplementary protection
LT - Pirolo[2,3-d]pirimidinilo, pirolo[2,3-b]pirazinilo ir pirolo[2,3-d]piridinilo akrilamidai
EN - PYRROLO[2,3-D]PYRIMIDINYL, PYRROLO[2,3-B]PYRAZINYL AND PYRROLO[2,3-D]PYRIDINYL ACRYLAMIDES
SPC
| (11) |
Number of the document |
C 3077395 |
| (68) |
Number of the document |
3077395
|
| (21) |
Application number for Supplementary Protection Certificate |
PA 2023 537 |
| (22) |
Date of filing the application |
2023-12-13 |
| (41) |
Date of publication of the application |
2024-01-10 |
|
Date of publication of SPC |
2025-09-10 |
| (24) |
Date of coming into effect of SPC |
2034-11-21 |
Applicant
| (71) |
Pfizer Inc.,
66 Hudson Boulevard East, New York, NY 10001-2192,
US
|
Grantee
| (73) |
Pfizer Inc.,
66 Hudson Boulevard East, New York, NY 10001-2192,
US
|
Attorney or representative
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
| (93) |
EU/1/23/1755, 2023-09-15
|
Calculated date of expiry of the SPC
| (94) |
2038-09-18 |
Name of the product protected by the basic patent
| (95) |
Ritlecitinibas arba farmaciniu požiūriu priimtina jo druska |
Legal status
|
SPC application published
|
|
